Business Description
Japan Lifeline Co Ltd
ISIN : JP3754500001
Total Employee Number:
1,609Description
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.08 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.22 | |||||
Interest Coverage | 370.94 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.82 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.4 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 10.8 | |||||
3-Year FCF Growth Rate | -10 | |||||
3-Year Book Growth Rate | 9.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.75 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 75.1 | |||||
9-Day RSI | 71.23 | |||||
14-Day RSI | 65.77 | |||||
3-1 Month Momentum % | -7.95 | |||||
6-1 Month Momentum % | -18.73 | |||||
12-1 Month Momentum % | -15.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.61 | |||||
Quick Ratio | 2.13 | |||||
Cash Ratio | 0.92 | |||||
Days Inventory | 287.92 | |||||
Days Sales Outstanding | 88.93 | |||||
Days Payable | 63.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.02 | |||||
Dividend Payout Ratio | 0.39 | |||||
3-Year Dividend Growth Rate | 12.4 | |||||
Forward Dividend Yield % | 4.15 | |||||
5-Year Yield-on-Cost % | 7.43 | |||||
3-Year Average Share Buyback Ratio | 3.4 | |||||
Shareholder Yield % | 5.61 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.43 | |||||
Operating Margin % | 21.31 | |||||
Net Margin % | 15.8 | |||||
EBITDA Margin % | 23.77 | |||||
FCF Margin % | 10.07 | |||||
OCF Margin % | 13.27 | |||||
ROE % | 15.16 | |||||
ROA % | 12.37 | |||||
ROIC % | 16.12 | |||||
3-Year ROIIC % | 19.22 | |||||
ROC (Joel Greenblatt) % | 32.08 | |||||
ROCE % | 19.88 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.37 | |||||
Forward PE Ratio | 10.24 | |||||
PE Ratio without NRI | 10.28 | |||||
Shiller PE Ratio | 13.47 | |||||
PEG Ratio | 0.58 | |||||
PS Ratio | 1.63 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 1.51 | |||||
Price-to-Free-Cash-Flow | 15.64 | |||||
Price-to-Operating-Cash-Flow | 11.86 | |||||
EV-to-EBIT | 7 | |||||
EV-to-EBITDA | 6.18 | |||||
EV-to-Revenue | 1.48 | |||||
EV-to-FCF | 13.91 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 0.71 | |||||
Price-to-DCF (Earnings Based) | 0.51 | |||||
Price-to-DCF (FCF Based) | 1.12 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.49 | |||||
Price-to-Graham-Number | 0.83 | |||||
| Price-to-Net-Current-Asset-Value | 2.79 | |||||
Earnings Yield (Greenblatt) % | 14.28 | |||||
FCF Yield % | 6.43 | |||||
Forward Rate of Return (Yacktman) % | 25.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Japan Lifeline Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 335.626 | ||
| EPS (TTM) (€) | 0.756 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 13.95 | ||
| 14-Day RSI | 65.77 | ||
| 14-Day ATR (€) | 0.067885 | ||
| 20-Day SMA (€) | 6.9575 | ||
| 12-1 Month Momentum % | -15.41 | ||
| 52-Week Range (€) | 6.65 - 8.745 | ||
| Shares Outstanding (Mil) | 70.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Japan Lifeline Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Japan Lifeline Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| JPY 54.000000 Cash Dividend | 2026-03-30 | 7.57 (+0.00%) | ||
| JPY 53.000000 Cash Dividend | 2025-03-28 | 9.57 (+0.00%) |
Show
Entries
Japan Lifeline Co Ltd Frequently Asked Questions
What is Japan Lifeline Co Ltd(FRA:L8B)'s stock price today?
The current price of FRA:L8B is €7.30. The 52 week high of FRA:L8B is €8.74 and 52 week low is €6.65.
When is next earnings date of Japan Lifeline Co Ltd(FRA:L8B)?
The next earnings date of Japan Lifeline Co Ltd(FRA:L8B) is .
Does Japan Lifeline Co Ltd(FRA:L8B) pay dividends? If so, how much?
The Dividend Yield %  of Japan Lifeline Co Ltd(FRA:L8B) is 4.02% (As of Today), Highest Dividend Payout Ratio of Japan Lifeline Co Ltd(FRA:L8B) was 0.41. The lowest was 0.21. And the median was 0.38. The  Forward Dividend Yield % of Japan Lifeline Co Ltd(FRA:L8B) is 4.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| CardioFocus® Announces Full Commercial Launch of HeartLight® System in Japan | 2018-07-11 |
Articles on Japan Lifeline Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers